Humanigen Inc (HGENQ)

[cowtown jay]

There's a lot more that went into preparing for this recall of the company's loaned shares, than we saw in the previous recall.

We spent millions on achieving the stellar results lenzilumab demonstrated in LIVE-AIR and in the PREACH-M trials. We have proven that lenz should be the Standard of Care for covid. That compares to previously leading with benznidazole for the treatment of Chagas Disease.

In addition, the PREACH-M interim results show CMML patients trending toward near-normal hematological parameters. This improvement could lead to treated patients undergoing bone marrow transplant, for the complete eradication of CMML cancer, as the RATinG study seems to be showing.

Also, we are forming partnerships that we didn't previously have. These partners are looking to advance their own platforms, CAR-T's, vaccines, and therapeutics, all of which are dramatically enhanced by incorporating lenz in their treatments.

Finally, I think management may have secured as much as 92% of the company's stock, greater than the 70% ownership previously obtained.